Showing results (21-30 of 44) with videos related to
Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2008
Soluble frizzled-related protein 1 is estrogen inducible in bone marrow stromal cells and suppresses the earliest events in lymphopoiesisTakafumi Yokota, Kenji Oritani, Karla P Garrett, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2007
IL-5-induced hypereosinophilia suppresses the antigen-induced immune response via a TGF-beta-dependent mechanismKazuyuki Nakagome, Makoto Dohi, Katsuhide Okunishi, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2011
Identification of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumor immunityMasashi Ikutani, Tsutomu Yanagibashi, Masaru Ogasawara, et al.Cancer Cell International|December 10, 2022
Evaluation of X-ray and carbon-ion beam irradiation with chemotherapy for the treatment of cervical adenocarcinoma cells in 2D and 3D culturesKazumasa Sekihara, Hidetomo Himuro, Nao Saito, et al.Nature Immunology|February 4, 2003
PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transductionHarumi Suzuki, Satoshi Matsuda, Yasuo Terauchi, et al.Immunity|September 23, 2003
Unique properties of fetal lymphoid progenitors identified according to RAG1 gene expressionTakafumi Yokota, Taku Kouro, Jun Hirose, et al.Frontiers in Pharmacology|November 29, 2023
Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinomaYosuke Shibata, Takeshi Kishida, Taku Kouro, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
Adiponectin, a fat cell product, influences the earliest lymphocyte precursors in bone marrow cultures by activation of the cyclooxygenase-prostaglandin pathway in stromal cellsTakafumi Yokota, C S Reddy Meka, Taku Kouro, et al.Seminars in Immunology|November 30, 2002
Lymphoid lineage cells in adult murine bone marrow diverge from those of other blood cells at an early, hormone-sensitive stagePaul W Kincade, Hideya Igarashi, Kay L Medina, et al.Cancer Immunology, Immunotherapy : CII|May 15, 2023
Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitorsHidetomo Himuro, Yoshiro Nakahara, Yuka Igarashi, et al.Pageof 5